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ESCHERICHIA COLI STRAINS PRODUCING
STREPTOCOCCUS MUTANS PROTEINS RESPONSIBLE
FOR COLONIZATION AND VIRULENCE*
Roy Curtiss III,t Robert G. Holt, RaGl G. Barletta
James P. Robeson,$ and Shigeno Saito
Institute of Dental Research
and
Department of Microbiology
University of Alabama in Birmingham
Birmingham, Alabama 35294

Streptococcus mutans is a principal etiologic agent of dental caries and is
likely one of the most ubiquitous bacterial infectious disease agents worldwide.'" The ability of S. mutans to colonize the oral cavity is due to sucroseindependent and sucrose-dependent adherence to the pellicle-coated tooth
surface with glucan facilitated aggregation between cells to result in plaque.
Cariogenicity is then caused by the ability of S. mutans in plaque to metabolize
free sugars and both extra and intracellular complex carbohydrates to yield
predominantly lactic acid.'" The S . mutans gene products that contribute to
colonizing ability and thus virulence include glucosyltransferases, glucanbinding proteins, and a diversity of less well-characterized cell-surface proteins
and carbohydrate antigens that may also promote adherence or aggregation.
Until recently, S. mutans was unable to be analyzed genetically by classical
methods of mutagenesis and gene transfer for mapping and complementation.
We thus chose to use gene cloning technologies to introduce S. mutans genes into
suitable strains of Escherichia coli K-12. S. mutans plasmid4and chromosoma15~7
genes are expressed very well in E. coli. For example, the S. rnutans gene for
aspartic acid semialdehyde dehydrogenase possesses a very unique promoter
sequence region that results in 7% of the total E. coli protein being the product of
this one S. mutans gene.',' Furthermore. S. mutans gene products can substitute
for E. coli gene products that are missing because of the presence of gene
mutations or deletions in the E. coli recipient strain.'.' In that regard, Perry and
Kuramitsu" have developed a method for transformation of S. mutans strain GS-5
(serotype c), making it possible to mutate S. mutans genes cloned in E. coli, to
return them to S. mutans and then to examine the effect of a known mutation
altering a well-characterized gene product on S. mutans virulence. Similarly, we
have been able to use antibodies against S. mutans gene products made by
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recombinant E. coli strains to select S. rnutans mutants lacking that gene
product.
We have begun systematically to clone S. mutans genes encoding cell-surface
proteins and then to determine the contribution of these gene products to the
ability of S. mutans to colonize the tooth surface. An associated objective is to use
some of the S. mutans gene products synthesized by recombinant E. coli clones
for the analysis of the immune response to S. mutans and for the development of
an effective anti-caries vaccine.
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FIGURE1. Strategy for successful cloning of S. rnutans genes specifying enzymes for
hydrolysis of sucrose into strains of E. coli K-12(see text].

Cloning of S. mutans Genes with Sucrose Hydrolyzing Activity

E. coli is unable to metabolize sucrose because of the absence of enzymes with
invertase-like activity and furthermore is unable to transport sucrose efficiently
across the cytoplasmic membrane. Because we were uncertain whether S. rnutans
gene products with sucrose hydrolyzing activity would leave the cytoplasm, it was
necessary to devise a means to present sucrose to such enzymes in the E. coli
1depicts the strategy for accomplishing this. The trisaccharide
cytoplasm. FIGURE
raffinose is an a-galactoside containing galactose and glucose in an a-1-6
linkage; thus raffinose can be transported across the E. coli cytoplasmic membrane by way of the galactoside permease that is the product of the lacy gene.
Raffinose can then induce expression of the genes in the mel operon with the
melA gene specifying an a-galactosidase that cleaves raffinose to yield galactose
and sucrose. We thus shotgun cloned S. rnutans PSI4 (serotype c) DNA using

FIGURE2. SDS-polyacrylamide gel electrophoresis of proteins in fractions containing
gtfA enzyme activity at different stages of purification. Activity was measured by generation
of reducing sugars from s ~ c r o s eLane
. ~ 1: crude extract of E. coli K-12 containing pYA6Ol
obtained by sonication followed by sedimentation of cell debris. Lane 2: fractions after
chromatography on a DE-52 column. Lane 3: fractions after chromatography on an Ultrogel
AcA54 column. Lane 4: fractions after chromatography on an Ultrogel AcA44 column. Lane
5: purified gtfA enzyme following precipitation with 33% ammonium sulfate. Lane 6:
molecular mass markers (kdal).
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the pBR322 plasmid cloning vector into an E. coli strain possessing a deletion of
the gal operon and selected recombinant clones able to grow on raffinose as the
~.~
of E. coli cells able to grow on raffinose with
sole carbon s ~ u r c e .Treatment
toluene led to a linear increase in the amount of reducing sugar generated over
time when sucrose was used as a substrate. One of the recombinant E. coli clones
with sucrose hydrolyzing activity contained a recombinant plasmid designated
pYA601. Analysis of proteins specified by the recombinant plasmid, pYA601,
using purified minicells containing the plasmid, revealed the presence of a 55,000
molecular weight protein encoded by 1730 base-pair fragment of S. rnutans DNA.
Based on the molecular weight of this protein, a strategy was devised for its
2). This purified protein could then be used
purification to homogeneity (FIGIJRE

FIGURE
3. Immunodiffusion analysis employing antibodies against purified gtfA protein
produced by E. colj (a-gtfA)and extracts of cell-surface proteins obtained from S. rnutons
strains in serotypes b, c, e, and f and the purified gtfA protein from the serotype c S. mutans
strain. PS14.

to prepare monospecific and monoclonal antibodies against the protein as well as
to characterize the protein for its enzyme activity.
that hydrolyzes
The protein encoded by pYA601 is a glucosyltran~ferase~~~
sucrose to synthesize a glucan polymer and an equivalent amount of fructose.
Antibody against the product of this gene that w e have designated gtfA reacts with
immunologically identical proteins from serotypes c, e, and f S. mutans strains
and cross-reacts with a protein from serotype b S. mutans (FIGURE
3). NO reaction
was detected with proteins produced by S. mutans serotypes a, d, or g.
The purified glucosyltransferase has a K, of 1.2 m M for sucrose, a pH
optimum of about 6.5 and hydrolyzes sucrose to a water-soluble glucan of low
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molecular weight and fructose. This glucosyltransferase does not require a
primer, and the protein is transported across the E. coli cytoplasmic membrane
into the periplasm without processing or modification. Thus, E. coli containing the
pYA601 plasmid can grow on sucrose because sucrose is transported across the
outer membrane into the E. coli periplasm. E. coli recombinants containing
pYA6Ol synthesize about 100,000 molecules of the gtfA enzyme per cell. This fact
accounts for about 3 to 4% of the total E. coli soluble protein.
Cloning of S. mutans Genes Specifying Cell-Surface Proteins Lacking
Enzyme Activity
DNA from S. rnutans strain 6715 (serotype g) was shotgun cloned into the
cosmid vector, pjC74,'O so as to reduce the size of the clone bank that would need
to be screened for expression of S. rnutans cell-surface protein antigens. The
cosmids packaged in vitro into infectious A-phage particles were introduced into
an E. colistrain lysogenic for the AcI857 thermo-inducible prophage and plated at
30°C. Colonies were patched onto an agarose medium containing high titer
antisera raised against S. rnutans cell-surface proteins, and after overnight
incubation at 30°C, the plates were shifted to 4Z°C to cause thermo-induction of
the A-prophage leading to lysis of cells and release of protein antigens that they
contain." Precipitin rings formed around those colonies expressing a protein
antigen reacting with the antibodies in the minimal agarose r n e d i ~ m . ~ , ' W nofe
the recombinant clones produced a strong precipitin band and has been studied
most extensively. This clone contained the recombinant cosmid, pYA721, that had
an 8.3 kilobase insert of S. rnutans 6715 DNA. This insert was subsequently
cloned into the plasmid vector, pACYC184, to yield the recombinant plasmid,
pYA726." We have designated the gene specifying this surface protein antigen as
spaA and have purified the spaA protein to homogeneity both from S. rnutans and
from E:. coli recombinants. The protein purified from S. rnutans has an apparent
molecular weight of 210,000 by SDS-polyacrylamide gel electrophoresis and of

F ~ C ~ J4.R E
Immunodiffusion analysis of cell-surface proteins produced by S. mutans
serotypes a, c. and g against antisera raised to purified spaA protein (a-spaA). It should he
noted that proteins from serotypes c. e, and f are all identical in regard to response to a-spaA
serum as are the proteins produced by serotypes d and g S. rnutans strains.
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TABLE
1
AMONGTHE
PRESENCE
OF ANTIGENSCROSS-REACTING
WITH 6715 SPAA PROTEIN
VARIOUSSEROTYPES
OF S. ~ I U T A N S
--

Strain
HS6
BHT
Ingbritt
OMZ176
LM7
OMZ175
6715

Serotype
a
b
c
d

e

f

8

Supernatant Fluid*
Yes
No
Yes
Yes
Yes
Yes
Yes

Cell Surfacet
Yes
No
Yes
Yes
Yes
Yes
Yes

*Extracellular protein fractions of the various S. mutans serotypes grown in defined
media" were prepared from cell-free culture supernatant fluids and were examined for
antigens cross-reacting with the spaA protein of S. rnutans 6715 by immunodiffusion
analysis.
t S . mutans cells of the \.arioussero!ypes were grown in defined media" and washed with
5 M NaCl. The presence of cell-surface antigens cross-reacting with the spaA protein of S.
rnutans 6715 was determined by direct immunofluoresence using rhodamine-conjugated
a-spaA as a probe.

180,000 when produced by E. coli. E. coli cells with the spaA gene produce 7°7~~
of
their total soluble protein as the spaA protein and translocate 60% of this protein
to the periplasmic space.12ThespaA protein reacts with antibody against the spaA
protein as well as with antibody against the antigen 1/11, purified and characterized from serotype c S. rnutans strains by Russell, et a).'= In addition, antibody
purified against the spaA protein reacts with antigen 1/11 from serotype c and also
with antigens produced by serotypes a, d, e, f, and g, but not by b strains of S.
mutans (FIGURE
4. TABLE
1).The spaA protein produced by S. rnutans contains an
antigenic determinant not present on the spaA protein produced by E. coli
recombinants. This phenomenon is possibly due to the absence of carbohydrate
antigenic determinants on the E. coli-produced gene product. This hypothesis is
currently under test. The spaA protein is found free in the supernatant fluid of S.
mutans strains grown in FMC medium" (TABLE
I],but is also found to be tightly
bound to the cell surface even after washing in 5 M NaCl. By using antibodies
directed against the spaA protein, it has been shown that these antibodies will
inhibit sucrose-induced aggregation between S. mutans cells. Furthermore, S.
mutans mutants lacking the spaA protein as selected by using antiserum against
the spaA protein are also defective in aggregation.

We have found that a diversity of S. mutans genes for cell-surface protein
antigens from both serotype c and serotype g strains are expressed very well in
strains of E. coli K-12. Furthermore, most of these S. rnutans cell-surface proteins
are able to be translocated across the E. coli cytoplasmic membrane into the E.
coli periplasm. Because of this fact, we are continuing to identify and characterize
other S. rnutans cell-surface protein antigens produced by recombinant E. coli
strains. Analysis of these proteins is facilitated by the fact that there are few, if
any, E. coli proteins that cross-react with S. rnutans proteins or vice versa.
Monoc~ona~
antibodies against the spaA and gtfA proteins have been produced
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from hybridomas,14 and these monoclonal antibodies are being used to facilitate
purification of the spaA and gtfA proteins by immunoabsorbent chromatography.
It should be pointed out that relatively satisfactory methods for the purification of
these proteins from E. coli, as well as S. rnutans, have been worked out.
Other workers have used purified glucosyltransferases15~'7
and the antigen 1/11
protein,'3 also termed B,".19 from serotype c and g S. rnutans strains to immunize
rats, hamsters, and Rhesus monkeys to evaluate induction of immunity to S.
mutans-induced dental caries. S ~ m e , ' ~but
. ' ~ not all.'"17 of these studies gave
promising results.
Because of these previous studies, the purified S. rnutans cell-surface proteins
are being used in several interrelated investigations. Dr. Michalek, Dr. McGhee,
and their colleagues are using these proteins, as well as lipoteichoic acid and
type-specific carbohydrate antigens, to screen humans as a function of age for
titers of various Ig isotypes in saliva and serum. Both enzyme-linked immunosorbent assays (ELISA]and radioimmunoassays (RIA)have been developed for most
of these S. mutans cell-surface proteins. These individuals are also being
evaluated for caries incidence, and for titers and serotypes of S. mutans in plaque.
High titers of antibodies, especially secretory IgA, against one or more of these
antigens in conjunction with low titers of S. rnutans in plaque and/or low
incidence of dental caries would be suggestive of protein antigens that should be
explored for their ability to induce protective immunity against S. mutansinduced dental caries.
In this last regard, we are collaborating with Dr. Mestecky. Dr. Michalek, Dr.
McGhee, and their colleagues to use purified protein antigens for oral (by gastric
intubation) and systemic immunization of mice and gnotobiotic rats to analyze the
immune response and evaluate effective immunity to S. rnutans-induced dental
caries. We have also devised a new approach for oral immunization so as to
stimulate cells of the Peyer's patches to result in a strong secretory IgA response.
Specifically, we are starting with enteric pathogens that are able to attach to and
invade cells of the gut-associated lymphoreticular tissue (GALT) and then
rendering them avirulent by genetic manipulation as used in our development of
the safer E. coli host, ~ 1 7 7 6 ,for recombinant DNA research.'" These avirulent
pathogens can then be endowed with genetic information to permit high-level
production of S. rnutans cell-surface protein antigens. and hecause of their ability
to attach to and invade cells of the GALT, we anticipate that a secretory immune
response against these S. mutuns protein antigens will be induced. If so, a safe
effective vaccine against S. rnutans-induced dental caries should become a
reality. In addition, this method would also be applicable to vaccine construction
and immunization to preclude infection by any viral, bacterial, mycotic, or
parasitic agent that invades a mucosal surface.

We thank Sylvia Larrirnore and Hettie Murchison for technical assistance and
Pat Pierce for help in preparation of this manuscript.
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T. LEHNER( G u y ' s H o s p i t a l , L o n d o n , E n g l a n d ) : I a m i m p r e s s e d b y the crossreactivity b e t w e e n serotypes, e x c e p t f o r s e r o t y p e b, w h i c h is a rat strain. Can you
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tell us whether there is complete or partial cross reactivity, because you have not
shown us all the data on this situation?
R. CURTISS(University of Alabama in Birmingham]: Only partial crossreactivity occurs here. Hopefully by using the cloned genes from serotypes c, a,
and g, we will be able to determine what particular domains in this very large
protein are shared and those that are dissimilar.
It also appears that this protein has the two antigen determinants that
LEHNER:
w e called antigens I and 11. Have you tried to digest away the antigen I component
of this antigen 1/11 complex to leave the antigen I1 behind?
CURTISS:Dr. Russell and Dr. Holt in our laboratory have shown that most of
the similarity between the spa A proteins from serotypes c and g seem to be in the
antigen I component.
LEHNER:
I was going to ask about the considerable ease with which you have
identified the antigen 1/11. What about the antigen III/IV? Have you found any
other synthesized by E. coli that you could use?
CURTISS:
We have quite a diversity of recombinant clones that produce at least
10 different S. mutans cell-surface proteins, and w e just have not characterized
all of these. They d o not have glucosyltransferase activity. One of the problems is
that w e have not used the antibodies against antigen I11 or IV to analyze any of our
clones. This method might be the simplest way, assuming that they will also be
cross-reactive.
L. J. SAIF(Ohio Agricultural Research and Development Center): For your
future studies, if you used avirulent enteric strains, d o you think that they, indeed,
would be able to attach and colonize?
CURTISS:
Yes. We are currently using derivatives of Salmonella and Salmonella-Escherichia hybrids. Others have used a Salmonella derivative that lacks the
ability to produce enterochelin. and although it is avirulent. this strain still
invades. The real problem with their mutant is that i t ends up in the spleen. where
it persists for several months. We are developing strains that will not get that far,
t ~ u hopefully,
t
will just hang up in the Peyer's patches.
M. BLAKE
(Rockefeller Ilniversity. New York, N.Y.): Do you have evidence
that your E:. coli regulates the genes that you are introducing?
CIIRTISS:
Yes.
BLAKE:Do you have any difficulty with a posttranslational modification
problem? Do you think that will he a problem in the future?
CURTISS:
The answer to the first question is yes. We d o get genes regulated in
some cases. Ordinarily. they are constitutively expressed in E. coli, in fact, at a
very high level But, a cluster of three or four genes for galactose metat)olism are
coordinately regulated in E. coli in the same manner as they are in S. mutuns.
Although we thought we had an operon, we did not. There are at least three
transcriptional units, and one of the gene products actually is a positive regulator
acting to cause increased synthesis of the other enzymes in the pathway.
In terms of posttranslation modification, we now have antibodies that are
directed at the unique antigenic determinants on some of these proteins made in
S. mutans that are not present on the proteins made in E. coli. These antibodies
are now being used to screen for cloning of the genes that would cause the
proteins in E. coli to be modified. So, by using sequential cloning, we assume that
we will be able to demonstrate the synthesis of glycoproteins by recombinant
techniques, where we have to introduce genes for several enzymes from the
donor-in this case S. mutans. This technique should then allow one to look at the
different antigens with and without the modifications, in terms of their ability to
induce a protective response.

